

Aïda Falgàs
23 posts

@aidafc8
Postdoctoral researcher at Stem cell biology, developmental leukemia and immunotherapy group in the Josep Carreras Leukaemia Research Institute



To minimize tumor antigen loss and reduce the risk of CD19+ leukemia progression in r/r B-ALL, Arroyo-Ródenas and Falgas et al. developed dual-targeted CD22 CAR T cells secreting an anti-CD19 T cell-engaging antibody (CAR-STAb-T). bit.ly/4mhBc4K @Alvarez_Vallina




❕🔬 A new CAR-T-cell therapy that tricks the tumour could increase treatment efficiency in B-cell Acute Lymphoblastic Leukaemia #ALL 👉 carrerasresearch.org/en/news/a-new-… 📋 Results published in @BloodJournal by researchers from @Menendez_Lab and @H12Octubre - @CNIOStopCancer







It has been a real pleasure to host @aidafc8 in our laboratory at @CNIOStopCancer @hospital12Oct for 3 months. Excellent work, as part of our strategic collaboration with @CarrerasIJC , @Menendez_Lab @clarabueno_74














🆕🔬 Researchers from @Menendez_Lab and @Hospital12deOct have developed a cell therapy based on STAb-T cells. This therapy could be used to treat T-Cell Acute Lymphoblastic Leukemia in those patients for whom previous treatments have not worked. 👉carrerasresearch.org/en/researchers…